文献速递重症综合管理与镇静镇痛儿科与产科急症

每日镇静中断与持续镇静在儿科机械通气患者中的比较:系统评价与Meta分析

Daily Sedation Interruption vs Continuous Sedation in Pediatric Patients Receiving Mechanical Ventilation: A Systematic Review and Meta-analysis.
PubMed 文献 · JAMA Netw Open · 2024-08-01
一句话结论在PICU机械通气患儿中,每日镇静中断与持续静脉镇静相比可缩短PICU停留时间(MD -1.45天),不增加不良事件,但机械通气时长无显著差异。

该系统评价与Meta分析检索5大数据库至2023年10月31日,纳入6项RCT共2810例PICU机械通气患儿(男性1569例[55.8%],平均年龄26.5个月,平均PRISM评分13.68)。与持续静脉镇静相比,每日镇静中断与PICU停留时间缩短相关(5项研究,n=2770;MD -1.45天,95%CI -2.75至-0.15;P=.03),机械通气时长无差异(5项研究,n=2750;MD -0.93天,95%CI -1.89至0.04;P=.06)。咪达唑仑总剂量(MD -1.66 mg/kg,95%CI -3.95至0.63)和吗啡总剂量(MD -2.63 mg/kg,95%CI -7.01至1.75)无差异,不良事件(RR 1.03,95%CI 0.74-1.42;P=.88)和死亡率(RR 0.89,95%CI 0.55-1.46;P=.65)无差异。作者认为需进一步研究该策略是否与PICU幸存者神经发育结局改善相关。

要点

  • 在PICU机械通气患儿中,每日镇静中断较持续静脉镇静缩短PICU停留时间:5项研究n=2770,MD -1.45天(95%CI -2.75至-0.15),P=.03。
  • 每日镇静中断未缩短机械通气时长:5项研究n=2750,MD -0.93天(95%CI -1.89至0.04),P=.06,未达统计学显著。
  • 每日镇静中断未增加不良事件:RR 1.03(95%CI 0.74-1.42),P=.88;死亡率无差异:RR 0.89(95%CI 0.55-1.46),P=.65。
  • 咪达唑仑总剂量(3项研究n=191;MD -1.66 mg/kg,95%CI -3.95至0.63)与吗啡总剂量(2项研究n=189;MD -2.63 mg/kg,95%CI -7.01至1.75)在每日镇静中断与持续镇静间无差异。
  • 作者认为需进一步研究每日镇静中断是否与PICU幸存者神经发育结局改善相关。

适用人群与场景

  • 年龄18岁及以下、在PICU接受有创机械通气的危重患儿。
  • 纳入比较每日镇静中断与持续静脉镇静的回顾性及前瞻性观察性研究、随机对照试验和系统评价。

研究设计与关键结果

  • 研究类型:系统评价与Meta分析,遵循PRISMA报告规范,采用随机效应模型合并结果;检索PubMed、Embase、Web of Science、CINAHL和Cochrane Central Register of Controlled Trials共5个数据库,检索时间自建库至2023年10月31日。
  • 纳入6项随机对照试验,共2810例PICU机械通气患儿;男性1569例(55.8%);平均年龄26.5个月(95%CI 15.0-37.9);平均PRISM评分13.68(95%CI 10.75-16.61)。
  • 主要结局:与持续静脉镇静相比,每日镇静中断与PICU停留时间缩短相关(5项研究,n=2770;MD -1.45天,95%CI -2.75至-0.15;P=.03);机械通气时长无差异(5项研究,n=2750;MD -0.93天,95%CI -1.89至0.04;P=.06)。
  • 次要结局:咪达唑仑总剂量无差异(3项研究,n=191;MD -1.66 mg/kg,95%CI -3.95至0.63);吗啡总剂量无差异(2项研究,n=189;MD -2.63 mg/kg,95%CI -7.01至1.75)。
  • 不良事件无差异(RR 1.03,95%CI 0.74-1.42;P=.88);每日镇静中断暴露组与非暴露组死亡率无差异(RR 0.89,95%CI 0.55-1.46;P=.65)。

证据类型、等级与局限

  • 证据类型:系统评价与Meta分析,纳入6项随机对照试验。
  • 局限:作者指出需进一步研究以确定该策略是否与PICU幸存者神经发育结局改善相关。

对床旁实践的改变

  • 在PICU机械通气患儿中,每日镇静中断与持续静脉镇静相比可能缩短PICU停留时间且不增加不良事件,但机械通气时长、镇静药物总剂量及死亡率无差异;作者认为需进一步研究神经发育结局。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: The effectiveness of daily sedation interruption (DSI, defined as temporary interruption of sedation) has yet to be demonstrated in critically ill pediatric patients.

OBJECTIVE: To compare the clinical outcomes of DSI vs continuous intravenous (IV) sedation in patients receiving invasive mechanical ventilation (MV) support in the pediatric intensive care unit (PICU).

DATA SOURCES: A systematic search for studies was conducted using predefined keywords and Medical Subject Headings in 5 major databases (PubMed, Embase, Web of Science, CINAHL [Cumulated Index to Nursing and Allied Health Literature], and Cochrane Central Register of Controlled Trials) from database inception to October 31, 2023.

STUDY SELECTION: Retrospective and prospective observational studies, randomized clinical trials (RCTs), and systematic reviews were assessed for inclusion. Studies were eligible if they compared DSI to continuous IV sedation in patients aged 18 years or younger requiring MV in the PICU.

DATA EXTRACTION AND SYNTHESIS: Study characteristics, including the types of sedation, sedation protocols, and clinical outcomes, were extracted. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) reporting guideline was followed. A random-effects model was used to pool results from articles for the meta-analysis.

MAIN OUTCOMES AND MEASURES: The primary outcomes of interest were duration of MV and length of PICU stay. Secondary outcomes included total sedative dose requirement, adverse events (eg, complications associated with MV, withdrawal, and delirium), and mortality.

RESULTS: A total of 6 RCTs with 2810 pediatric patients (1569 males [55.8%]; mean age, 26.5 [95% CI, 15.0-37.9] months) were included in the final analysis; patients had a mean PRISM (Pediatric Risk of Mortality) score of 13.68 (95% CI, 10.75-16.61). Compared with continuous IV sedation, DSI was associated with a reduction in length of PICU stay (5 studies, n = 2770; mean difference [MD], -1.45 [95% CI, -2.75 to -0.15] days; P = .03]. There was no difference in MV duration (5 studies, n = 2750; MD, -0.93 [95% CI, -1.89 to 0.04] days; P = .06), total doses of midazolam (3 studies, n = 191; MD, -1.66 [95% CI, -3.95 to 0.63] mg/kg) and morphine used (2 studies, n = 189; MD, -2.63 [95% CI, -7.01 to 1.75] mg/kg), or adverse events (risk ratio [RR], 1.03 [95% CI, 0.74-1.42]; P = .88). There was no difference in mortality between patients exposed vs not exposed to DSI (RR, 0.89 [95% CI, 0.55-1.46]; P = .65).

CONCLUSIONS AND RELEVANCE: This systematic review and meta-analysis found that use of DSI in pediatric patients was associated with reduced length of PICU stay with no increase in adverse events. Further research is needed to ascertain whether this strategy is associated with improved neurodevelopmental outcomes in PICU survivors.

来源:JAMA Netw Open,查看原文。版权归原作者所有。

参考来源

  1. Shu Wen Toh T, R R P, Ho KHY, et al. Daily Sedation Interruption vs Continuous Sedation in Pediatric Patients Receiving Mechanical Ventilation: A Systematic Review and Meta-analysis. JAMA Netw Open. 2024. PMID: 39110460. doi:10.1001/jamanetworkopen.2024.26225

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。